ArticleBMC pregnancy and childbirth2026
Pre-hospital healthcare for hyperemesis gravidarum: a cross-sectional analysis of baseline data from the SUKK-P study.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWomen suffering fromhyperemesis gravidarum need timely and appropriate treatment to alleviate symptoms and prevent complications to the mother and fetus.
aimThe aim of this study was to identify and analyze treatment given prior to hospitalization to women included in the SUKK-P study.
methodsThis study presents cross-sectional analyses at enrollment in the prospective SUKK-P cohort study of hyperemesis gravidarum (HG) treatment. Women hospitalized for HG were included from 11 departments within Norway between February 2021 and December 2023. Self-reported symptom severity and its impact on daily life at inclusion, treatment and health care received prior to hospitalization were collected by survey and chart review.
resultsThe majority (89%) of the 214 women included in SUKK-P had sought health care for nausea and vomiting during pregnancy (NVP)/HG prior to hospitalization. Although 88% had used one or more antiemetics prior to hospitalization, 42% were on sick leave for nausea prior to being offered antiemetic treatment. The median PUQE-score at hospitalization was 14 (interquartile range (IQR) 12-15) with a median wellbeing score of 2 (IQR 1-3). The participants reported severe impact on daily life in terms of reduced ability to perform household chores, care for children, and socialize. Nearly all (99%) were feeling low or depressed to some degree, and nine of ten reported that the nausea impacted the relationship with their partners. Half of the women reported having thoughts about terminating the pregnancy. One or more additional symptoms were reported by 97% with headache and hopelessness or feeling low as the most frequent, closely followed by difficulty sleeping, acid reflux, and constipation.
conclusionsWomen with hyperemesis gravidarum describe high level of distress, still there is a delay in being provided antiemetics as 42% reported provision of sick leave as first healthcare measure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.